Elevated LGALS3 expression has been reported in a variety of malignancies, including glioblastoma, breast cancer, melanoma, colorectal cancer, hepatocellular carcinoma, and pancreatic ductal adenocarcinoma [5,6,7]. Here, LGALS3 is linked to pancreatic ductal adenocarcinoma.